Inari Medical, Inc. NARI 43.47 Inari Medical, Inc.

Home
⇒ 
Stock List ⇒ Inari Medical, Inc.
Range:36.73-67.13Vol Avg:909568Last Div:0Changes:1.17
Beta:1Cap:2.44BCurrency:USDExchange:NASDAQ
Sector:HealthcareIPO:Fri May 22 2020Empoloyees:1300
CUSIP:45332Y109CIK:0001531048ISIN:US45332Y1091Country:US
CEO:Mr. Andrew J. HykesWebsite:https://www.inarimedical.com
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Stock Details

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow